Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

NCT01618825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Fed

Interventions

DRUG: Lamotrigine Tablets 25 mg
DRUG: Lamotrigine

Sponsor

IPCA Laboratories Ltd.